I am neither long or short.....I do have a problem with the FDA approving drugs without adequate testing to determine their efficacy. If there isn't credible data it shouldn't be on the market.
that's the line being spewed on cnbc by Cramer and Co.
low interest rates now the subject of discussion - Hey geniuses they people controlling interest rates are the ones with all the debt! Duh! If rates rise governments go broke and social services end.
P.T. say he ate 3 candy bars yesterday andf coke's not a bad thing because it only has as much sugar as 1 candy bar! Sorry P.T., but I don't believe you ate 3 candy bars yesterday. I'm beginning to see you as a real B.S. artist.
Charity Navigator, which is the largest independent evaluator of charities, gives MDA two out of four stars based on Financial, Accountability, and Transparency Performance Metrics.
mitrochondrial DNA or some other genetic mediated disease
The kids and their parents shouldn't have been there. SRPT turned this into a public relations circus and the FDA allowed it. The only thing that matters is the data. This story reminds me of Dendreon whose drug didn't work, but was approved due to outside pressure. The ultimate power behind Dendreon's lobbying efforts, like SRPT's were those who were going to make money.
The business of selling false hope is a great one on wall street
the sec and us attorney should take a close look at sarepta....preying on the most vulnerable group of pediatric patients to make millions,,,,a 12 person study?
no cars in parking lot on Saturday....looked like a ghost town.....Vicor just down the street booimg - parking lot was full on saturday lots of O.T .
your statement that you wouldn;t bet against a stock that helped people is the crux of the argument, the only people being helped here appear to be the insiders and investment banks that are lining their pockets by selling false hope.
no science behind its trial